蛋白质组学
蛋白质组
再生障碍性贫血
外体
医学
定量蛋白质组学
骨髓增生异常综合症
微泡
血液蛋白质类
生物
免疫学
癌症研究
信号转导
微泡
生物信息学
转录组
外周血
钙连接素
生物标志物发现
抗体微阵列
计算生物学
免疫印迹
造血
生物标志物
基因表达谱
诊断生物标志物
细胞凋亡
血细胞
小RNA
作者
David Z. He,Dingding Li,Ming Liu,Lin Li,Mingjie Gao,Heran Li,Yuting Zhao,Qi Zhao,Xin Yue,Fei Tian,Jinhuan Wang
标识
DOI:10.1021/acs.jproteome.5c00700
摘要
Non-severe aplastic anemia (NSAA) and myelodysplastic syndrome-hypoplastic (MDS-h) are common hematological disorders. Their similar clinical symptoms and lab investigations make diagnosis challenging. To discern their differences and facilitate diagnosis, we utilized blood exosomes and employed a quantitative proteomics approach. Exosomes were extracted, identified from peripheral blood plasma of 20 NSAA, 10 MDS-h patients, and 10 healthy subjects, and then analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Subcellular localization, GO, KEGG, and Mfuzz analyses determined differentially expressed protein (DEPs) features. Candidate proteins were validated via parallel reaction monitoring (PRM) analysis using plasma exosome samples from the above-mentioned subjects. LC-MS/MS identified 62 DEPs in MDS-h and 68 in the NSAA versus MDS-h (C/M) comparison. Functional enrichment analysis of DEPs indicated their involvement in lipid metabolism regulation in MDS-h, while those in C/M were related to signal transduction and immunomodulation. Mfuzz analysis yielded four large clusters with significant differences among the three sample groups. PRM analysis identified C4A, APOA1, and SERPINF2, with their expression validated by ELISA in NSAA, MDS-h, and healthy subjects. Herein, we characterized exosomal proteome profiles of NSAA and MDS-h patients, screening, and validating valuable candidate proteins. This work informs the differential diagnosis and mechanistic research of the NSAA and MDS-h.
科研通智能强力驱动
Strongly Powered by AbleSci AI